FDA approved midazolam auto injector

Other Transaction IDV Awarded Last action

Contract number
W911SR2390004
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order
Not on record
IDV ceiling
$48,471,340.83
Contracting staff
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Other

Award details come from SAM.gov/FPDS.

About this IDV

The Joint Program Executive Office for Chemical and Biological Defense awarded an Other Transaction IDV to Rafa Laboratories LTD on December 8, 2022, with a ceiling value of $48,478,620.53. This OT IDV sits outside the Federal Acquisition Regulation and enables flexible procurement to support chemical and biological defense medical countermeasures. Rafa Laboratories LTD, a foreign-owned manufacturer based in Jerusalem, Israel, specializes in the development and production of FDA-approved autoinjectors for emergency medical preparedness. The OT IDV is structured as a multiple-award vehicle for manufacturing and delivering FDA-approved midazolam autoinjectors, which contain a sedative and anesthetic agent designed for self-administration in chemical and biological defense scenarios. Rafa Laboratories brings established capability in medical device design, regulatory compliance, and production of specialized autoinjector systems for federal defense applications.

Transactions

Action Obligated Date
Other Administrative Action P00012 · To manufacture and deliver food and drug administration (FDA) approved autoinjectors containing midazolam. $0
Funding Only Action P00011 · To manufacture and deliver food and drug administration (FDA) approved -$7,250
Funding Only Action P00010 $434,612
Other Administrative Action P00009 $0
Funding Only Action P00008 · To manufacture and deliver food and drug administration (FDA) approved autoinjectors containing midazolam. $4,206,428
Funding Only Action P00007 $3,279,349
Funding Only Action P00006 · To manufacture and deliver food and drug administration approved autoinjectors containing midazolam. $4,188,622
Funding Only Action P00005 · Manufacture and deliver food and drug administration (FDA) approved midazolam autoinjectors. -$94,132
Funding Only Action P00004 · To manufacture and deliver food and drug administration approved autoinjectors containing midazolam. $16,436,763
Supplemental Agreement for work within scope P00003 · Incorporate incremental funding of $2,308,194.27 for additional FDA approved midazolam auto injectors $2,308,194
Other Administrative Action P00002 $0
Funding Only Action P00001 $10,839,940
Original award $6,871,564
Show all 13

Quick answers

Who was awarded contract W911SR2390004?

W911SR2390004 was awarded to Rafa Laboratories LTD by ACC Aberdeen Proving Ground (Army Contracting Command) on December 8, 2022.

How much is contract W911SR2390004 worth?

W911SR2390004's own ceiling is $48,471,341.

Which agency awarded contract W911SR2390004?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2390004, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911SR2390004 competed?

The extent of competition for W911SR2390004 was not competed.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV